News by Tag: Gene Therapy Pfizer
Allovectin-7 to Enlarge Gene Therapy Revenue Patterns
April 16, 2012
Allovectin-7 (velimogene aliplasmid) is anticipated to generate estimated revenue worth US$ 400 Million in the US after its projected launch in 2012-2013, says RNCOS.
April 16, 2012
Allovectin-7 (velimogene aliplasmid) is anticipated to generate estimated revenue worth US$ 400 Million in the US after its projected launch in 2012-2013, says RNCOS.
Global Gene Therapy Market Estimated to Reach US$ 325 Million by 2015
April 5, 2012
The gene therapy market is expanding worldwide at an impressive rate, and continuous technological developments will continue to spur the growth, says RNCOS.
April 5, 2012
The gene therapy market is expanding worldwide at an impressive rate, and continuous technological developments will continue to spur the growth, says RNCOS.